PNV 2.35% $2.61 polynovo limited

The Clinicians Speak, page-1040

  1. 7,525 Posts.
    lightbulb Created with Sketch. 1282
    Loved this extract

    "Unlike other artificial dermal templates that are comprised of allogenic or xenogenic materials, the fully synthetic BTM eliminates the possibility of inter-species immune rejection or disease transmission and avoids ethical or cultural obstacles"
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.